Infantile Spasm Therapeutics Market Outlook 2025: Advances in Pediatric Epilepsy Treatment
Market Overview The global infantile spasm therapeutics market size was valued at US$ 136.96 million in 2023 and is projected to grow at a CAGR of 3.2% during the forecast period. Infantile spasms, also known as West syndrome, are a rare but severe form of epilepsy that typically occurs in the first year of life. This neurological disorder is characterized by sudden, brief muscle contractions that can lead to developmental delays and long-term neurological complications if not treated early. The increasing awareness among healthcare providers and parents, advancements in diagnostic technology, and ongoing research and development initiatives are contributing significantly to the market’s expansion. Additionally, the development of more targeted therapeutic approaches and improved access to treatment across emerging economies are expected to support the steady growth of the market over the next several years. Key Market Growth Drivers Increasing Awareness and Early Diagnosis...